<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href='static/style.xsl' type='text/xsl'?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-22T10:30:03Z</responseDate><request verb="GetRecord" identifier="oai:ecommons.cornell.edu:1813/102924" metadataPrefix="dim">https://ecommons.cornell.edu/server/oai/request</request><GetRecord><record><header><identifier>oai:ecommons.cornell.edu:1813/102924</identifier><datestamp>2026-05-15T19:44:11Z</datestamp><setSpec>com_1813_35</setSpec><setSpec>col_1813_47</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="author">Ramezani, Meraj</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="chair">Baird, Barbara A.</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="committeeMember">Crane, Brian</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="committeeMember">Lin, Hening</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2021-03-12T17:39:18Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2021-03-12T17:39:18Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued">2020-08</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other">ProQuest Submission ID: 12109</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other">ProQuest Publication ID: 28027359</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://hdl.handle.net/1813/102924</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="doi">https://doi.org/10.7298/f567-x578</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="bibid">13277696</dim:field>
   <dim:field mdschema="dc" element="description">210 pages</dim:field>
   <dim:field mdschema="dc" element="description">Supplemental file(s) description: Supplementary Movie 2.2b-Confocal-RBL-2H3-wt-syn-low-1ng-antigen, Supplementary Movie 2.2a-Confocal-RBL-2H3-pcDNA-control-1ng-antigen, Supplementary Movie 2.1c-TIRF-RBL-2H3-wt-syn-high-thapsigargin, Supplementary Movie 2.1b-TIRF-RBL-2H3-wt-syn-low-thapsigargin, Supplementary Movie 2.1a-TIRF-RBL-2H3-pcDNA-control-thapsigargin.</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract">Alpha-synuclein (a-syn) is a major component of Lewy bodies, a neuropathology observed in Parkinson’s disease (PD) and other related neurodegenerative disorders. Oligomeric species formed during a-syn aggregation process have been linked to impairments caused by PD, but the normal physiological function of a-syn and dysregulation leading to PD remain ambiguous. Much of our knowledge concerning a-syn stems from in-vitro studies focused on the aggregation process and on membrane binding properties. Despite the development of cell and animal models, the functional consequence of a-syn’s structural interactions remain poorly defined. By using multiple mammalian cell models, including RBL cells, effects of a-syn on specific cell processes can be measured and analyzed. Considering the localization of a-syn to nerve terminals and its affinity for binding phospholipid vesicles, modulation of the trafficking of vesicles, including synaptic vesicles is a likely function of a-syn. We investigated phenotypes of a-syn overexpression in RBL and PC-12 cells by monitoring stimulated exocytosis of recycling endosomes (REs) as a proxy for synaptic vesicles that are similar in size. We demonstrated that low expression levels of a-syn inhibit exocytosis of REs while higher expression levels lead to some enhancement. Using NMR spectroscopy, we demonstrated that membrane binding properties of a-syn variants correlate with the functional outcomes. In particular, perturbation in helix 1 or helix 2 of a-syn N-terminal region by proline mutations, specifically affects both participation in RE exocytosis and binding affinity. Conversely C-terminal truncation and PD-related mutations behave similarly to wt a-syn at low expression levels in the exocytosis assay. Furthermore, we found that wt a-syn binds weakly to mitochondria unlike the proline mutants and that the binding becomes considerably stronger upon mitochondrial stress. Building on our findings that a-syn binds to mitochondria, we demonstrated that expression of a-syn enhances stimulated mitochondrial Ca2+ uptake in RBL cells. We validated this observation in the HEK293 cell line which is commonly used as a model for neurons. We found that proline mutations disrupting helix 1 or 2 of a-syn nullifies this enhancing effect, consistent with the N-terminal membrane binding portion of a-syn facilitating the increase in mitochondrial Ca2+ uptake. By controlling the source of Ca2+ we found that the Ca2+ for mitochondrial uptake comes mainly from the endoplasmic reticulum (ER). Structured illumination microscopy showed that increase in mitochondrial Ca2+ uptake correlates with increase in contacts between ER and mitochondria. We further established that a-syn enhances the mitochondrial Ca2+ uptake in a neuronal cell line (differentiated dopaminergic N2a cells). We discovered and investigated a novel inhibitory effect of a-syn on recovery from mitochondrial stress caused by PD inducing toxins. Interestingly this inhibitory effect appears to depend on the unstructured C-terminal tail of a-syn. These results highlight the significance of specific structural features of a-syn in regulating vesicle release and modulating mitochondrial Ca2+ uptake, and they reveal a novel pathological function for a-syn under mitochondrial stress related to PD.</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso">en</dim:field>
   <dim:field mdschema="dc" element="rights">Attribution 4.0 International</dim:field>
   <dim:field mdschema="dc" element="rights" qualifier="uri">https://creativecommons.org/licenses/by/4.0/</dim:field>
   <dim:field mdschema="dc" element="subject">Mitochondria</dim:field>
   <dim:field mdschema="dc" element="subject">Parkinson</dim:field>
   <dim:field mdschema="dc" element="subject">Synuclein</dim:field>
   <dim:field mdschema="dc" element="subject">Trafficking</dim:field>
   <dim:field mdschema="dc" element="title">Mammalian cell models for investigating alpha-synuclein modulation of vesicle trafficking and interaction with mitochondria</dim:field>
   <dim:field mdschema="dc" element="type">dissertation or thesis</dim:field>
   <dim:field mdschema="dc" element="relation" qualifier="localuri">https://catalog.library.cornell.edu/catalog/13277696</dim:field>
   <dim:field mdschema="dc" element="format" qualifier="mimetype">application/pdf</dim:field>
   <dim:field mdschema="dc" element="format" qualifier="mimetype">video/avi</dim:field>
   <dim:field mdschema="thesis" element="degree" qualifier="discipline">Chemistry and Chemical Biology</dim:field>
   <dim:field mdschema="thesis" element="degree" qualifier="grantor">Cornell University</dim:field>
   <dim:field mdschema="thesis" element="degree" qualifier="level">Doctor of Philosophy</dim:field>
   <dim:field mdschema="thesis" element="degree" qualifier="name">Ph. D., Chemistry and Chemical Biology</dim:field>
   <dim:field mdschema="dcterms" element="license">https://hdl.handle.net/1813/59810</dim:field>
   <dim:field mdschema="dspace" element="entity" qualifier="type">Publication</dim:field>
   <dim:field mdschema="cris" element="virtual" qualifier="collection" authority="https://cornell-ecommons.eks.prod.4science.cloud/handle/1813/47" confidence="600">Cornell Theses and Dissertations</dim:field>
   <dim:field mdschema="cris" element="virtual" qualifier="author">Ramezani, Meraj</dim:field>
   <dim:field mdschema="cris" element="virtualsource" qualifier="collection">5893a6ea-7af3-41d7-abc6-04bcd26ab5df</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
   <dim:field mdschema="cerif" element="openaire" authority="" confidence="-1">&lt;Publication xmlns="https://www.openaire.eu/cerif-profile/1.1/" id="167974d7-85e9-4e59-a4bc-58de2c00dba7">
	&lt;Type xmlns="https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types">http://purl.org/coar/resource_type/c_1843&lt;/Type>
	&lt;Language>en&lt;/Language>
   	&lt;Title>Mammalian cell models for investigating alpha-synuclein modulation of vesicle trafficking and interaction with mitochondria&lt;/Title>
   	&lt;PublishedIn>
    	&lt;Publication>
      	&lt;/Publication>
   	&lt;/PublishedIn>
   	&lt;PublicationDate>2020-08&lt;/PublicationDate>
   	&lt;DOI>https://doi.org/10.7298/f567-x578&lt;/DOI>
   	&lt;Authors>
      	&lt;Author>
        	&lt;DisplayName>Ramezani, Meraj&lt;/DisplayName>
         	&lt;Affiliation>
         		&lt;OrgUnit>
         		&lt;/OrgUnit>
         	&lt;/Affiliation>
      	&lt;/Author>
	&lt;/Authors>
   	&lt;Editors>
	&lt;/Editors>
    &lt;Publishers>
        &lt;Publisher>
            &lt;OrgUnit />
        &lt;/Publisher>
    &lt;/Publishers>
    &lt;License>https://creativecommons.org/licenses/by/4.0/&lt;/License>
    &lt;Keyword>Mitochondria&lt;/Keyword>
    &lt;Keyword>Parkinson&lt;/Keyword>
    &lt;Keyword>Synuclein&lt;/Keyword>
    &lt;Keyword>Trafficking&lt;/Keyword>
   	&lt;Abstract>Alpha-synuclein (a-syn) is a major component of Lewy bodies, a neuropathology observed in Parkinson’s disease (PD) and other related neurodegenerative disorders. Oligomeric species formed during a-syn aggregation process have been linked to impairments caused by PD, but the normal physiological function of a-syn and dysregulation leading to PD remain ambiguous. Much of our knowledge concerning a-syn stems from in-vitro studies focused on the aggregation process and on membrane binding properties. Despite the development of cell and animal models, the functional consequence of a-syn’s structural interactions remain poorly defined. By using multiple mammalian cell models, including RBL cells, effects of a-syn on specific cell processes can be measured and analyzed. Considering the localization of a-syn to nerve terminals and its affinity for binding phospholipid vesicles, modulation of the trafficking of vesicles, including synaptic vesicles is a likely function of a-syn. We investigated phenotypes of a-syn overexpression in RBL and PC-12 cells by monitoring stimulated exocytosis of recycling endosomes (REs) as a proxy for synaptic vesicles that are similar in size. We demonstrated that low expression levels of a-syn inhibit exocytosis of REs while higher expression levels lead to some enhancement. Using NMR spectroscopy, we demonstrated that membrane binding properties of a-syn variants correlate with the functional outcomes. In particular, perturbation in helix 1 or helix 2 of a-syn N-terminal region by proline mutations, specifically affects both participation in RE exocytosis and binding affinity. Conversely C-terminal truncation and PD-related mutations behave similarly to wt a-syn at low expression levels in the exocytosis assay. Furthermore, we found that wt a-syn binds weakly to mitochondria unlike the proline mutants and that the binding becomes considerably stronger upon mitochondrial stress. Building on our findings that a-syn binds to mitochondria, we demonstrated that expression of a-syn enhances stimulated mitochondrial Ca2+ uptake in RBL cells. We validated this observation in the HEK293 cell line which is commonly used as a model for neurons. We found that proline mutations disrupting helix 1 or 2 of a-syn nullifies this enhancing effect, consistent with the N-terminal membrane binding portion of a-syn facilitating the increase in mitochondrial Ca2+ uptake. By controlling the source of Ca2+ we found that the Ca2+ for mitochondrial uptake comes mainly from the endoplasmic reticulum (ER). Structured illumination microscopy showed that increase in mitochondrial Ca2+ uptake correlates with increase in contacts between ER and mitochondria. We further established that a-syn enhances the mitochondrial Ca2+ uptake in a neuronal cell line (differentiated dopaminergic N2a cells). We discovered and investigated a novel inhibitory effect of a-syn on recovery from mitochondrial stress caused by PD inducing toxins. Interestingly this inhibitory effect appears to depend on the unstructured C-terminal tail of a-syn. These results highlight the significance of specific structural features of a-syn in regulating vesicle release and modulating mitochondrial Ca2+ uptake, and they reveal a novel pathological function for a-syn under mitochondrial stress related to PD.&lt;/Abstract>
	&lt;Access xmlns="http://purl.org/coar/access_right" 
    >
    &lt;/Access>
&lt;/Publication>
</dim:field>
</dim:dim>
</metadata></record></GetRecord></OAI-PMH>